Exploring the role of EZH2 (PRC2) as epigenetic target

被引：0

作者：

Aier, Imlimaong ^{[1
]}

Raj, Utkarsh ^{[1
]}

机构：

[1] IIIT Allahabad, Dept Appl Sci, Allahabad, Uttar Pradesh, India

来源：

2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB) | 2016年

关键词：

EZH2; prostate cancer; breast cancer; virtual screening; molecular docking; INHIBITION; LYMPHOMA;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Polycomb group (PcG) proteins have been observed to maintain the pattern of histone by methylation of the histone tail responsible for the gene expression in various cellular processes. The PcG protein consists of two multicomplex, Polycomb Repressive Complexes 1 and 2, which includes Enhancer of zeste homolog 2 (EZH2) acting so that the histones silences tumor suppressor genes. Overexpression of EZH2 results in hyper activation observed in various forms of cancer, for instance, prostate and breast cancer. In the past decade, potent inhibitors for EZH2 have been discovered. However, reports of natural compounds for targeting EZH2 is significantly less. The druglikeness and pharmacokinetic properties of several natural compounds were analyzed and the compound with top inhibitory property was studied by molecular docking. A GLIDE score of - 8.223 kcal/mol with stable interaction between the protein and ligand was observed for a simulation of 50 ns. This suggests the use of selected compound as an effective inhibitor for EZH2.

引用

页数：4

共 7 条

[1]

Antonysamy S, 2013, STRUCTURAL CONTEXT D, DOI [10.1371/journal.pone.0084147, DOI 10.1371/JOURNAL.PONE.0084147]

[2] The Protein Data Bank [J].

Berman, HM ;

Battistuz, T ;

Bhat, TN ;

Bluhm, WF ;

Bourne, PE ;

Burkhardt, K ;

Iype, L ;

Jain, S ;

Fagan, P ;

Marvin, J ;

Padilla, D ;

Ravichandran, V ;

Schneider, B ;

Thanki, N ;

Weissig, H ;

Westbrook, JD ;

Zardecki, C .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :899-907

[3]

Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]

[4] Improved side-chain torsion potentials for the Amber ff99SB protein force field [J].

Lindorff-Larsen, Kresten ;

Piana, Stefano ;

Palmo, Kim ;

Maragakis, Paul ;

Klepeis, John L. ;

Dror, Ron O. ;

shaw, David E. .

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (08) :1950-1958

[5] EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations [J].

McCabe, Michael T. ;

Ott, Heidi M. ;

Ganji, Gopinath ;

Korenchuk, Susan ;

Thompson, Christine ;

Van Aller, Glenn S. ;

Liu, Yan ;

Graves, Alan P. ;

Della Pietra, Anthony, III ;

Diaz, Elsie ;

LaFrance, Louis V. ;

Mellinger, Mark ;

Duquenne, Celine ;

Tian, Xinrong ;

Kruger, Ryan G. ;

McHugh, Charles F. ;

Brandt, Martin ;

Miller, William H. ;

Dhanak, Dashyant ;

Verma, Sharad K. ;

Tummino, Peter J. ;

Creasy, Caretha L. .

NATURE, 2012, 492 (7427) :108-+

[6] Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation [J].

Qi, Wei ;

Chan, HoMan ;

Teng, Lin ;

Li, Ling ;

Chuai, Shannon ;

Zhang, Ruipeng ;

Zeng, Jue ;

Li, Min ;

Fan, Hong ;

Lin, Ying ;

Gu, Justin ;

Ardayfio, Ophelia ;

Zhang, Ji-Hu ;

Yan, Xiaoxia ;

Fang, Jialuo ;

Mi, Yuan ;

Zhang, Man ;

Zhou, Tao ;

Feng, Grace ;

Chen, Zijun ;

Li, Guobin ;

Yang, Teddy ;

Zhao, Kehao ;

Liu, Xianghui ;

Yu, Zhengtian ;

Lu, Chris X. ;

Atadja, Peter ;

Li, En .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (52) :21360-21365

[7] Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments [J].

Sastry, G. Madhavi ;

Adzhigirey, Matvey ;

Day, Tyler ;

Annabhimoju, Ramakrishna ;

Sherman, Woody .

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (03) :221-234

← 1 →